Titan pharmaceuticals inc
WebAbout Titan Pharmaceuticals. Titan Pharmaceuticals, Inc. (NASDAQ:TTNP), based in South San Francisco, CA, is a development stage company developing proprietary therapeutics with its ProNeura® long-term, continuous drug delivery technology. The ProNeura technology has the potential to be used in developing products for treating a number of ... WebApr 14, 2024 · Titan Pharmaceuticals, Inc. engages in the development of therapeutics for the treatment of chronic diseases utilizing its long-term, continuous drug delivery …
Titan pharmaceuticals inc
Did you know?
WebApr 15, 2024 · Titan Pharmaceuticals, Inc engages in the development of therapeutics for the treatment of chronic diseases utilizing its long-term, continuous drug delivery platform, ProNeura. Its lead product is Probuphine, a buprenorphine implant for the maintenance treatment of opioid addiction. The company was founded by Louis R. WebIn October 2024, Titan entered into an Asset Purchase Agreement with JT Pharmaceuticals, Inc., or JT Pharma, for the acquisition and development of JT Pharma’s kappa opioid agonist peptide, TP-2024 (formerly JT-09), for use in combination with the ProNeura technology.
WebSOUTH SAN FRANCISCO, Calif., Nov. 30, 2024 /PRNewswire/ -- Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) ("Titan" or the "Company") today announced that its Board of Directors has approved a 1-for-30 reverse stock split of the Company's common stock, which will be effective at 5:00 p.m. Eastern Time on Monday, November 30, 2024. The Company's ... WebFeb 1, 2024 · Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) is a development-stage biotechnology company developing proprietary therapeutics using its clinically proven ProNeura® long-term, continuous drug ...
WebTitan Pharmaceuticals, Inc. is a development-stage biotechnology company developing proprietary therapeutics using its clinically proven ProNeura® long-term, continuous drug delivery technology. WebPharmaceutical. Charlotte, NC. 16 Total Employees. Prinston Pharmaceutical, Inc. is a fully integrated pharmaceutical company engaged in product development, product …
WebTitan Pharmaceuticals has worked with the FDA to develop the Probuphine REMS Program to mitigate the risk of complications of migration, protrusion, expulsion, and nerve damage associated with the insertion and removal of Probuphine and the risks of accidental overdose, misuse and abuse. REMS Program Overview
WebTitan Pharmaceuticals, Inc. Daily – Vickers Top Buyers & Sellers for 01/27/2024 The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase ... clown tang tank sizeWebApr 13, 2024 · Titan Pharmaceuticals, Inc engages in the development of therapeutics for the treatment of chronic diseases utilizing its long-term, continuous drug delivery platform, ProNeura. Its lead product ... cabinet knock downWebTitan Pharmaceuticals, Inc., a pharmaceutical company, develops therapeutics for the treatment of chronic diseases. It develops products based on ProNeura, a proprietary long-term drug delivery platform. cabinet lambert fontenay sous boisWebLegal Name Titan Pharmaceuticals, Inc. Stock Symbol NASDAQ:TTNP Company Type For Profit Contact Email [email protected] Phone Number 6502440715 Titan Pharmaceuticals, Inc. is a biopharmaceutical Company developing proprietary therapeutics primarily for the treatment of serious medical disorders. cabinet knowledgeWebApr 6, 2024 · Titan Pharmaceuticals, Inc. SEC Filing - Annual Report (10-K) March 25, 2024 Titan Pharmaceuticals, Inc. SEC Filing - Securities Registration Statement (S-1) February … clown tapping on windowTitan Pharmaceuticals, Inc. is a development-stage biotechnology company developing proprietary therapeutics using its clinically proven ProNeura® long-term, continuous drug delivery technology. The ProNeura technology has the potential to be used in developing products for treating a number of chronic conditions where maintaining consistent, around-the-clock blood levels of med… clown tang careWebSustained Anti-Pruritic Effect Of Titan's TP-2024 Implant Reported Today At Neuroscience 2024. November 8, 2024. clown tapestry